IQVIA, a global healthcare analytics and research group, estimates the global marketExternal link for anti-obesity drugs could grow from $66 billion in 2025 to $100-$200 billion a year by 2030
Each treatment plan begins with a consultation to understand the patients needs and determine whether this approach is appropriate
Novo Nordisk did not answer questions about how its drugs may be influencing dining habits, but a spokesperson said in a statement that the effectiveness of the GLP-1 medication semaglutide in people who are overweight or obese is well-established, with "strong evidence" of improved health outcomes
One branch stimulates responses related to our fight-or-flight instinct increased heart rate, dilated pupils, sweat secretion while the other initiates the rest-and-restore mode
He sees India as a clear beneficiary of this expansion
This expectation was verified based on findings of this study